Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HASSAN M ALISSA

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1770522633
CMS profile
171278
Location
SAN MARCOS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$897.35

50 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $897.35 50

By paying entity

PY2019 · entire year · sorted by reported total

Page 1 of 1; records 1–50 of 50 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HASSAN M ALISSA

NPI 1770522633 · CMS profile ID 171278

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

SAN MARCOS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–50 of 50 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1770522633?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HASSAN M ALISSA, NPI 1770522633, CMS profile ID 171278. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–50 of 50 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1770522633?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). HASSAN M ALISSA, NPI 1770522633, CMS profile ID 171278. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–50 of 50 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1770522633?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
HASSAN M ALISSA, NPI 1770522633, CMS profile ID 171278, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–50 of 50 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1770522633?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

50 matching records · $897.35 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 50 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 50.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie, Inc. $21.0912/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647800545 CMS
PFIZER INC. $13.9012/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673779319 CMS
Amgen Inc. $21.1711/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662383293 CMS
UCB, Inc. $15.2011/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688335563 CMS
E.R. Squibb & Sons, L.L.C. $16.5411/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651400715 CMS
Genentech USA, Inc. $12.7511/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681408433 CMS
GENZYME CORPORATION $13.8710/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694191495 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.4110/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700162635 CMS
Novartis Pharmaceuticals Corporation $21.2110/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658949011 CMS
AbbVie, Inc. $24.7410/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647800549 CMS
AbbVie, Inc. $21.5310/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647800541 CMS
Genentech USA, Inc. $19.7410/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681418103 CMS
Amgen Inc. $24.6510/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662383281 CMS
Flexion Therapeutics, Inc. $20.6509/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 705843327 CMS
Hikma Pharmaceuticals USA $14.1709/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688413223 CMS
Amgen Inc. $18.6609/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662383290 CMS
Amgen Inc. $22.5509/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662383277 CMS
Genentech USA, Inc. $23.4309/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681409651 CMS
PFIZER INC. $14.2109/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672826769 CMS
PFIZER INC. $14.8208/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672492562 CMS
Celgene Corporation $23.5008/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672892059 CMS
PFIZER INC. $12.9008/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672654043 CMS
Lilly USA, LLC $16.2907/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657841579 CMS
PFIZER INC. $21.6207/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672353221 CMS
Novartis Pharmaceuticals Corporation $19.3206/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658949009 CMS
E.R. Squibb & Sons, L.L.C. $19.8206/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651400671 CMS
Mallinckrodt Enterprises LLC $30.1606/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704805421 CMS
Amgen Inc. $21.2705/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662383273 CMS
GlaxoSmithKline, LLC. $16.1205/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670908341 CMS
PFIZER INC. $4.1505/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672184011 CMS
Janssen Biotech, Inc. $22.9805/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658300383 CMS
PFIZER INC. $17.8905/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672180333 CMS
Radius Health, Inc. $17.0705/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683932445 CMS
Hikma Pharmaceuticals USA $19.6804/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688413181 CMS
AbbVie, Inc. $13.5904/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647800543 CMS
PFIZER INC. $12.8304/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672225755 CMS
GENZYME CORPORATION $23.4204/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694017609 CMS
Celgene Corporation $18.8604/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673002275 CMS
PFIZER INC. $5.2403/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672221288 CMS
Amgen Inc. $18.3403/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662383287 CMS
PFIZER INC. $12.3103/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672173019 CMS
AbbVie, Inc. $22.5003/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647800547 CMS
Amgen Inc. $23.3603/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662383283 CMS
UCB, Inc. $16.8002/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688257687 CMS
PFIZER INC. $17.0002/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672173699 CMS
PFIZER INC. $4.6802/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672161616 CMS
PFIZER INC. $11.2102/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672243057 CMS
Mallinckrodt Enterprises LLC $31.6001/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704805419 CMS
E.R. Squibb & Sons, L.L.C. $11.8001/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651400651 CMS
GlaxoSmithKline, LLC. $16.7501/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671319475 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $897.35 50
PY2020 $213.68 11
PY2021 $658.55 37
PY2022 $887.91 42
PY2023 $1,012.46 46
PY2024 $982.62 50
PY2025 $651.60 25

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $11,361.50 3
PY2023 Principal investigator $3,982.90 1
PY2022 Principal investigator $7,900.10 4
PY2021 Principal investigator $19,195.60 3
PY2020 Recipient $754.50 1
PY2020 Principal investigator $308,127.13 57
PY2019 Recipient $3,425.78 1
PY2019 Principal investigator $171,615.03 60

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

58 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 GlaxoSmithKline, LLC. $6,243.30 12/09/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 24-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, EFFICACY AN No dispute reported 06/30/2026 753909127
Principal investigator 1 AbbVie Inc. $1,500.00 10/29/2020 Non-covered Recipient Entity
INTERSPOND LLC
M13-542 No dispute reported 06/30/2026 721193551
Principal investigator 1 AbbVie Inc. $1,500.00 10/16/2020 Non-covered Recipient Entity
INTERSPOND LLC
M15-555 No dispute reported 06/30/2026 721191329
Principal investigator 1 GlaxoSmithKline, LLC. $1,654.20 10/14/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 52-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE BLIND, EFFICACY AN No dispute reported 06/30/2026 734922617
Principal investigator 1 GlaxoSmithKline, LLC. $2,178.90 10/09/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 52-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE BLIND, EFFICACY AN No dispute reported 06/30/2026 734919433
Principal investigator 1 GlaxoSmithKline, LLC. $3,880.80 10/05/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 24-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, EFFICACY AN No dispute reported 06/30/2026 734926983
Principal investigator 1 GlaxoSmithKline, LLC. $500.00 10/01/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 5-YEAR PROSPECTIVE OBSERVATIONAL REGISTRY TO ASSESS ADVERSE EVENTS O No dispute reported 06/30/2026 734912657
Principal investigator 1 AbbVie Inc. $1,407.90 09/30/2020 Non-covered Recipient Entity
INTERSPOND LLC
M13-542 No dispute reported 06/30/2026 721189225
Principal investigator 1 AbbVie Inc. $1,716.40 09/30/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
M15-572 No dispute reported 06/30/2026 721189523
Principal investigator 1 AbbVie Inc. $3,711.06 08/28/2020 Non-covered Recipient Entity
INTERSPOND LLC
M13-542 No dispute reported 06/30/2026 721183641
Principal investigator 1 GlaxoSmithKline, LLC. $241.00 08/14/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 5-YEAR PROSPECTIVE OBSERVATIONAL REGISTRY TO ASSESS ADVERSE EVENTS O No dispute reported 06/30/2026 734914173
Principal investigator 1 AbbVie Inc. $1,953.14 07/30/2020 Non-covered Recipient Entity
INTERSPOND LLC
M13-542 No dispute reported 06/30/2026 721178245
Principal investigator 1 AbbVie Inc. $450.00 07/30/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
M15-572 No dispute reported 06/30/2026 721178459
Principal investigator 1 AbbVie Inc. $3,455.38 07/28/2020 Non-covered Recipient Entity
INTERSPOND LLC
M15-555 No dispute reported 06/30/2026 721176987
Principal investigator 1 GlaxoSmithKline, LLC. $4,765.50 07/16/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 52-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE BLIND, EFFICACY AN No dispute reported 06/30/2026 734913879
Principal investigator 1 GlaxoSmithKline, LLC. $964.00 07/15/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 5-YEAR PROSPECTIVE OBSERVATIONAL REGISTRY TO ASSESS ADVERSE EVENTS O No dispute reported 06/30/2026 734910403
Recipient Eli Lilly and Company $754.50 07/09/2020 Covered Recipient Physician A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS No dispute reported 06/30/2026 728719927
Principal investigator 1 AbbVie Inc. $1,460.39 06/30/2020 Non-covered Recipient Entity
INTERSPOND LLC
M13-542 No dispute reported 06/30/2026 721173555
Principal investigator 1 AbbVie Inc. $1,680.44 06/30/2020 Non-covered Recipient Entity
INTERSPOND LLC
M15-555 No dispute reported 06/30/2026 721173557
Principal investigator 1 AbbVie Inc. $2,630.60 06/30/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
M15-572 No dispute reported 06/30/2026 721173727
Principal investigator 1 GlaxoSmithKline, LLC. $1,513.80 06/25/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 24-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, EFFICACY AN No dispute reported 06/30/2026 734908955
Principal investigator 1 GlaxoSmithKline, LLC. $241.00 06/25/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 5-YEAR PROSPECTIVE OBSERVATIONAL REGISTRY TO ASSESS ADVERSE EVENTS O No dispute reported 06/30/2026 734928365
Principal investigator 1 GlaxoSmithKline, LLC. $2,014.20 06/23/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 52-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE BLIND, EFFICACY AN No dispute reported 06/30/2026 734928301
Principal investigator 1 GlaxoSmithKline, LLC. $2,455.00 06/15/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 5-YEAR PROSPECTIVE OBSERVATIONAL REGISTRY TO ASSESS ADVERSE EVENTS O No dispute reported 06/30/2026 734914169
Principal investigator 1 GlaxoSmithKline, LLC. $6,355.80 06/08/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 24-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, EFFICACY AN No dispute reported 06/30/2026 734908091
Principal investigator 1 Janssen Research & Development, LLC $2,534.00 06/02/2020 Non-covered Recipient Entity
Interspond Llc
Comparative and Pragmatic Study of Simponi Aria Versus No dispute reported 06/30/2026 719503169
Principal investigator 1 GlaxoSmithKline, LLC. $8,163.00 06/01/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 52-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE BLIND, EFFICACY AN No dispute reported 06/30/2026 734903043
Principal investigator 1 AbbVie Inc. $1,419.89 05/27/2020 Non-covered Recipient Entity
INTERSPOND LLC
M15-555 No dispute reported 06/30/2026 721167399
Principal investigator 1 Genentech, Inc. $1,563.50 05/18/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS PLLC
PH II OLE OF GDC 0853 IN ERL No dispute reported 06/30/2026 857142213
Principal investigator 1 GlaxoSmithKline, LLC. $5,211.90 05/14/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 24-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, EFFICACY AN No dispute reported 06/30/2026 734920343
Principal investigator 1 AbbVie Inc. $1,460.39 04/30/2020 Non-covered Recipient Entity
INTERSPOND LLC
M13-542 No dispute reported 06/30/2026 721164031
Principal investigator 1 AbbVie Inc. $2,839.78 04/27/2020 Non-covered Recipient Entity
INTERSPOND LLC
M15-555 No dispute reported 06/30/2026 721162305
Principal investigator 1 AbbVie Inc. $2,000.00 04/23/2020 Non-covered Recipient Entity
INTERSPOND LLC
M13-542 No dispute reported 06/30/2026 721161949
Principal investigator 1 GlaxoSmithKline, LLC. $1,822.50 04/20/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 24-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, EFFICACY AN No dispute reported 06/30/2026 734901047
Principal investigator 1 GlaxoSmithKline, LLC. $11,910.60 04/02/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 52-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE BLIND, EFFICACY AN No dispute reported 06/30/2026 734910653
Principal investigator 1 Genentech, Inc. $1,000.00 04/01/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS PLLC
PH II OLE OF GDC 0853 IN ERL No dispute reported 06/30/2026 857142209
Principal investigator 1 GlaxoSmithKline, LLC. $8,764.20 04/01/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 24-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, EFFICACY AN No dispute reported 06/30/2026 734904221
Principal investigator 1 AbbVie Inc. $1,857.29 03/30/2020 Non-covered Recipient Entity
INTERSPOND LLC
M13-542 No dispute reported 06/30/2026 721158661
Principal investigator 1 AbbVie Inc. $15.60 03/30/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
M15-572 No dispute reported 06/30/2026 721158935
Principal investigator 1 AbbVie Inc. $1,487.39 03/26/2020 Non-covered Recipient Entity
INTERSPOND LLC
M15-555 No dispute reported 06/30/2026 721157213
Principal investigator 1 GlaxoSmithKline, LLC. $1,446.00 03/12/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 5-YEAR PROSPECTIVE OBSERVATIONAL REGISTRY TO ASSESS ADVERSE EVENTS O No dispute reported 06/30/2026 734902729
Principal investigator 1 GlaxoSmithKline, LLC. $9,202.50 03/09/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 24-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, EFFICACY AN No dispute reported 06/30/2026 734903747
Principal investigator 1 AbbVie Inc. $1,857.29 02/28/2020 Non-covered Recipient Entity
INTERSPOND LLC
M13-542 No dispute reported 06/30/2026 721153515
Principal investigator 1 AbbVie Inc. $2,841.00 02/28/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
M15-572 No dispute reported 06/30/2026 721153791
Principal investigator 1 AbbVie Inc. $2,648.34 02/20/2020 Non-covered Recipient Entity
INTERSPOND LLC
M15-555 No dispute reported 06/30/2026 721151533
Principal investigator 1 GlaxoSmithKline, LLC. $8,388.00 02/17/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 52-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE BLIND, EFFICACY AN No dispute reported 06/30/2026 734907613
Principal investigator 1 GlaxoSmithKline, LLC. $9,727.00 02/14/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 5-YEAR PROSPECTIVE OBSERVATIONAL REGISTRY TO ASSESS ADVERSE EVENTS O No dispute reported 06/30/2026 734928045
Principal investigator 1 Janssen Research & Development, LLC $835.00 02/12/2020 Non-covered Recipient Entity
Interspond Llc
Comparative and Pragmatic Study of Simponi Aria Versus No dispute reported 06/30/2026 719503157
Principal investigator 1 GlaxoSmithKline, LLC. $3,371.40 02/11/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 24-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, EFFICACY AN No dispute reported 06/30/2026 734903745
Principal investigator 1 GlaxoSmithKline, LLC. $768.00 02/03/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 5-YEAR PROSPECTIVE OBSERVATIONAL REGISTRY TO ASSESS ADVERSE EVENTS O No dispute reported 06/30/2026 734904447
Principal investigator 1 AbbVie Inc. $1,460.39 01/30/2020 Non-covered Recipient Entity
INTERSPOND LLC
M13-542 No dispute reported 06/30/2026 721148451
Principal investigator 1 Eli Lilly and Company $145,362.60 01/29/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS No dispute reported 06/30/2026 728730471
Principal investigator 1 AbbVie Inc. $4,780.77 01/27/2020 Non-covered Recipient Entity
INTERSPOND LLC
M15-555 No dispute reported 06/30/2026 721147091
Principal investigator 1 Genentech, Inc. $520.20 01/20/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS PLLC
PH II OLE OF GDC 0853 IN ERL No dispute reported 06/30/2026 743030703
Principal investigator 1 Eli Lilly and Company $2,472.69 01/09/2020 Non-covered Recipient Entity
WEST TENNESSE RESEARCH INSTITUTE
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS No dispute reported 06/30/2026 728750215
Principal investigator 1 GlaxoSmithKline, LLC. $1,054.00 01/02/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 5-YEAR PROSPECTIVE OBSERVATIONAL REGISTRY TO ASSESS ADVERSE EVENTS O No dispute reported 06/30/2026 734904891
Principal investigator 1 GlaxoSmithKline, LLC. $1,529.10 01/02/2020 Non-covered Recipient Entity
ARTHRITIS CLINIC OF CENTRAL TEXAS
A 52-WEEK, PHASE 3, MULTICENTRE, RANDOMISED, DOUBLE BLIND, EFFICACY AN No dispute reported 06/30/2026 734907939
Principal investigator 1 Janssen Research & Development, LLC $3,340.00 01/02/2020 Non-covered Recipient Entity
Interspond Llc
Comparative and Pragmatic Study of Simponi Aria Versus No dispute reported 06/30/2026 719503145